Lung health for all:Focus more on the cardiopulmonary risk in patients with COPD  

作　　者：Rongchang Chen Jiefu Yang 

机构地区：[1]Guangzhou Institute of Respiratory Health(Stake Key Lab of Respiratory Disease),The First Affiliated Hospital of Guangzhou Medical University,Guangzhou,Guangdong 510000,China [2]Shenzhen Institute of Respiratory Diseases,Shenzhen People’s Hospital,Shenzhen,Guangdong 518000,China [3]Department of Cardiology,Beijing Hospital,National Center of Gerontology,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing 100000,China

出　　处：《Chinese Medical Journal》2024年第13期1513-1515,共3页中华医学杂志（英文版）

摘　　要：Chronic obstructive pulmonary disease(COPD),the third leading cause of death worldwide,led to approximately 3.23 million deaths in 2019 and imposed significant economic and health burdens.However,cardiovascular mortality accounts for approximately one-third of deaths in patients with COPD,[1]particularly in those with mild or moderate disease severity.[2]Studies have also identified a substantial increase in the risk of cardiovascular events in patients with COPD.[3,4]Given the notable risk of cardiopulmonary(pulmonary and cardiovascular)events in COPD,the management of COPD should incorporate strategies aiming at reducing the risk of cardiopulmonary events.Optimized treatment of patients with COPD may reduce their risk of cardiopulmonary events and potentially enhance survival benefit.Fully understanding the risk of cardiovascular events in patients with COPD is crucial for comprehensive management of disease.Thus,this article aims to offer an update on the risk of cardiovascular events in COPD and emphasize the importance of cooperation between pulmonologists and cardiologists.

关 键 词：PATIENTS CARDIOPULMONARY CARDIOVASCULAR 

分 类 号：R563.9[医药卫生—呼吸系统]